GRFS vs NXTS Stock Comparison

Grifols and Nexentis Technologies Prices as of Oct 26, 2026 Peers: Industry group
GRFS Grifols SA
$7.92 +7.8% 1M -16.3% 1Y
Market cap
$5.52B
P/E
11.9x
Revenue (TTM)
—
Div. yield
–
Biotechnology Healthcare
5 wins

Head to Head

5 decided of 12

Grifols leads on 5 of the 12 questions below (Grifols 5). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionGRFSNXTSLeader
Larger companyMarket capitalisation $5.52B $465.12K GRFS
Cheaper on earningsLower P/E, profitable companies only 11.9x 0.0x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 8.4x — –
Faster revenue growthRevenue growth, trailing twelve months — — –
More profitableNet margin, trailing twelve months — — –
Better return on capitalReturn on invested capital — — –
Less leveragedLower net debt / EBITDA — 1.6x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -16.3% -97.9% GRFS
Better 5-year returnAnnualised price return, 5 years -9.9%/yr -86.1%/yr GRFS
Less volatileAnnualised volatility, 1 year 32.4% 169.1% GRFS
Higher overall scoreMean of the five percentile scores vs peers 57/100 32/100 GRFS

Percentile Scorecard

GRFSNXTS

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisGRFSNXTS
Valuation 99 #6 of 626 –
Growth – 13 #526 of 604
Profitability – 40 #333 of 555
Financial Health 14 #566 of 658 44 #372 of 658
Shareholder Returns 56 #161 of 368 –
Overall 57 32
  • GRFS ranked among 673 companies in Pharmaceuticals and Biotechnology
  • NXTS ranked among 673 companies in Pharmaceuticals and Biotechnology

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodGRFSNXTSSPY
1 month +7.8%-61.9% -0.8%
3 months +2.2%-66.5% +3.5%
6 months -2.6%-88.4% +7.0%
Year to date -15.3%-95.2% +12.2%
1 year -16.3%-97.9% +13.0%
3 years +1.0%-99.9% +86.3%
3 years, per year +0.3%-89.6% +23.1%
5 years -40.5%-100.0% +68.6%
5 years, per year -9.9%-86.1% +11.0%
10 years -46.6%-100.0% +258.0%
10 years, per year -6.1%-66.6% +13.6%

Risk

MeasureGRFSNXTSSPY
Volatility, 1Y 32.4%169.1% 12.7%
Downside volatility, 1Y 34.1%153.3% 12.7%
Beta vs S&P 500, 1Y 0.952.31 1.00
Return / volatility, 1Y -0.50-0.58 1.02
Max drawdown, 5Y -58.9%-100.0% -25.4%
From 52-week high -18.5%-97.8% -1.8%
52-week high $9.72$26.04 $779.14
52-week low $7.02$0.53 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleGRFSNXTS
P/E now vs peer median 11.9xmedian 17.1x 0.0xmedian 17.1x
P/S now vs peer median 0.6xmedian 8.8x —median 8.8x
EV/EBITDA now vs peer median —median 17.1x 1.5xmedian 17.1x
P/FCF now vs peer median 7.6xmedian 18.0x —median 18.0x
P/B now vs peer median 0.6xmedian 2.1x 0.2xmedian 2.1x
PEG now vs peer median —median 0.31 0.00median 0.31

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsGRFSNXTS
Operating income – -$5.28M
Net income – -$14.06M
R&D – $532.00K
EPS (diluted) – $-17.10
Cash & equivalents $969.15M $7.62M
Total debt $44.00B $3.22M
Shares (diluted) 681.57M 816.14K
Enterprise value $1.86B -$22.18M

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricGRFSNXTS
P/E 11.9x 0.0x
P/FCF 7.6x –
P/Operating cash flow – –
P/S 0.6x –
P/B 0.6x 0.2x
P/Tangible book 0.9x -0.2x
EV/EBITDA – 1.5x
EV/EBIT – 1.5x
EV/Revenue – –
EV/FCF – –
EV/Operating cash flow – –
PEG (3Y EPS CAGR) – 0.00

Growth

14 metrics
MetricGRFSNXTS
Revenue growth (1Y) – –
Revenue CAGR (3Y) – –
Gross profit growth (1Y) – –
Gross profit CAGR (3Y) – –
Operating income growth (1Y) – -7.7%
Operating income CAGR (3Y) – 3.0%
Net income growth (1Y) – -48.2%
Net income CAGR (3Y) – -35.8%
EPS growth (1Y) – -567.8%
EPS CAGR (3Y) – -45.2%
Operating cash flow growth (1Y) – –
Operating cash flow CAGR (3Y) – –
Free cash flow growth (1Y) – –
Free cash flow CAGR (3Y) – –

Profitability

14 metrics
MetricGRFSNXTS
Gross margin – –
EBITDA margin – –
Operating margin – –
Pretax margin – –
Net margin – –
FCF margin – –
Operating cash flow margin – –
Return on equity – -157.0%
Return on assets – -71.9%
Return on invested capital – –
Return on capital employed – -31.5%
Asset turnover – –
Cash conversion (OCF / net income) – –
Stock comp / revenue – –

Financial Health

11 metrics
MetricGRFSNXTS
Debt / assets 48.9% 2.3%
Debt / equity 1.3x 0.2x
Net debt / EBITDA – 1.6x
Debt / FCF – –
Liabilities / assets 61.4% 89.8%
Equity / assets 38.6% 10.2%
Interest coverage – –
Current ratio 2.5x 3.7x
Quick ratio 0.8x 3.2x
Cash ratio 0.4x 3.2x
Altman Z-score – –

Shareholder Returns

7 metrics
MetricGRFSNXTS
Dividend yield 1.4% –
Net buyback yield – –
Shareholder yield 1.4% –
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusGRFSNXTS
Forward P/E 8.4xFY2026 –
EPS, next fiscal year $0.94FY2026 –
EPS growth, next FY +10.6%FY2026 –
EPS growth, the year after +26.6% –
Revenue, next fiscal year $8.88BFY2026 –
Revenue growth, next FY +0.0%FY2026 –
Revenue growth, the year after +10.3% –

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersGRFSNXTS
Held by institutions 21.0% –
Institutions holding 166 –
Change in shares held, QoQ -0.5% –
Institutions buying 73 –
Institutions selling 65 –
Buyers to sellers 1.12 –

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

GRFSNXTS
GRFS 1.00 0.03
NXTS 0.03 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, GRFS and NXTS?

Grifols (GRFS) is the largest by market capitalisation: Grifols (GRFS) $5.52B, Nexentis Technologies (NXTS) $465.12K.

Which stock has performed better?

Over the past year Grifols (GRFS) returned the most: Grifols (GRFS) -16.3%, Nexentis Technologies (NXTS) -97.9%. Over five years, Grifols (GRFS) compounded fastest (Grifols (GRFS) -9.9%/yr, Nexentis Technologies (NXTS) -86.1%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Grifols (GRFS) has been the steadiest (Grifols (GRFS) 32.4%, Nexentis Technologies (NXTS) 169.1%). Volatility measures how widely the price swings, not the risk of the business.

Do GRFS and NXTS move together?

Their daily returns over the past year have a correlation of 0.03, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, GRFS and NXTS?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Grifols (GRFS) leads on 5. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.